BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27622658)

  • 1. SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.
    Tumbarello DA; Andrews MR; Brenton JD
    PLoS One; 2016; 11(9):e0162698. PubMed ID: 27622658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
    Tumbarello DA; Temple J; Brenton JD
    Mol Cancer; 2012 May; 11():36. PubMed ID: 22640878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel.
    Ahmed AA; Mills AD; Ibrahim AE; Temple J; Blenkiron C; Vias M; Massie CE; Iyer NG; McGeoch A; Crawford R; Nicke B; Downward J; Swanton C; Bell SD; Earl HM; Laskey RA; Caldas C; Brenton JD
    Cancer Cell; 2007 Dec; 12(6):514-27. PubMed ID: 18068629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C.
    Steitz AM; Steffes A; Finkernagel F; Unger A; Sommerfeld L; Jansen JM; Wagner U; Graumann J; Müller R; Reinartz S
    Cell Death Dis; 2020 Apr; 11(4):249. PubMed ID: 32312959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.
    Nummela P; Lammi J; Soikkeli J; Saksela O; Laakkonen P; Hölttä E
    Am J Pathol; 2012 Apr; 180(4):1663-74. PubMed ID: 22326753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential.
    Lauden L; Siewiera J; Boukouaci W; Ramgolam K; Mourah S; Lebbe C; Charron D; Aoudjit F; Jabrane-Ferrat N; Al-Daccak R
    J Invest Dermatol; 2014 Jun; 134(6):1675-1685. PubMed ID: 24499734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.
    Said N; Najwer I; Motamed K
    Am J Pathol; 2007 Mar; 170(3):1054-63. PubMed ID: 17322388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.
    Ween MP; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2012; 13(8):10461-10477. PubMed ID: 22949874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling.
    Hellinger JW; Schömel F; Buse JV; Lenz C; Bauerschmitz G; Emons G; Gründker C
    Sci Rep; 2020 Oct; 10(1):17889. PubMed ID: 33087801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.
    Wen G; Hong M; Li B; Liao W; Cheng SK; Hu B; Calaf GM; Lu P; Partridge MA; Tong J; Hei TK
    Int J Oncol; 2011 Oct; 39(4):1001-9. PubMed ID: 21701776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway.
    Wang H; Xu YH; Guo Y
    J Ovarian Res; 2024 Feb; 17(1):50. PubMed ID: 38395907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
    Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
    Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC Is Highly Expressed in Young Skin and Promotes Extracellular Matrix Integrity in Fibroblasts via the TGF-β Signaling Pathway.
    Ham SM; Song MJ; Yoon HS; Lee DH; Chung JH; Lee ST
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinoma.
    Shang D; Xian S; Han T; Li X; Liu Y
    J BUON; 2017; 22(4):1038-1045. PubMed ID: 28952225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone.
    Chlenski A; Guerrero LJ; Salwen HR; Yang Q; Tian Y; Morales La Madrid A; Mirzoeva S; Bouyer PG; Xu D; Walker M; Cohn SL
    PLoS One; 2011; 6(9):e23880. PubMed ID: 21949685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.
    Wang N; Zhang H; Yao Q; Wang Y; Dai S; Yang X
    J Exp Clin Cancer Res; 2012 Jan; 31(1):6. PubMed ID: 22248469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.
    Haber CL; Gottifredi V; Llera AS; Salvatierra E; Prada F; Alonso L; Sage EH; Podhajcer OL
    Int J Cancer; 2008 Apr; 122(7):1465-75. PubMed ID: 18059024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
    Weaver MS; Sage EH; Yan Q
    J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
    Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
    Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
    Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.